WESTLAKE CHEM CORP's ticker is WLK and the CUSIP is 960413102. A total of 334 filers reported holding WESTLAKE CHEM CORP in Q1 2023. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $512,642 | +48.0% | 4,112 | +41.8% | 0.00% | +33.3% |
Q2 2023 | $346,463 | -79.9% | 2,900 | -82.7% | 0.00% | -78.6% |
Q4 2022 | $1,722,672 | -84.0% | 16,800 | -86.4% | 0.01% | -84.4% |
Q3 2022 | $10,757,000 | -2.2% | 123,816 | +10.3% | 0.09% | -15.9% |
Q2 2022 | $11,000,000 | +1287.1% | 112,223 | +1645.8% | 0.11% | +1428.6% |
Q1 2022 | $793,000 | -96.7% | 6,428 | -97.4% | 0.01% | -96.8% |
Q4 2021 | $24,361,000 | +33.3% | 250,812 | +25.1% | 0.22% | +16.9% |
Q3 2021 | $18,277,000 | +1711.4% | 200,541 | +1690.5% | 0.19% | +1618.2% |
Q2 2021 | $1,009,000 | -81.8% | 11,200 | -82.0% | 0.01% | -83.6% |
Q1 2021 | $5,534,000 | +1720.4% | 62,329 | +1199.6% | 0.07% | +1016.7% |
Q3 2020 | $304,000 | -81.6% | 4,796 | -84.4% | 0.01% | -72.7% |
Q2 2020 | $1,650,000 | +599.2% | 30,766 | +812.7% | 0.02% | +266.7% |
Q4 2019 | $236,000 | -89.2% | 3,371 | -87.2% | 0.01% | -93.8% |
Q3 2018 | $2,186,000 | -17.3% | 26,300 | -17.3% | 0.10% | -59.8% |
Q3 2017 | $2,642,000 | +874.9% | 31,798 | +529.7% | 0.24% | +423.9% |
Q3 2016 | $271,000 | – | 5,050 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lorem Ipsum Management, LLC | 75,000 | $4,582,000 | 3.38% |
Select Equity Group, L.P. | 2,691,291 | $164,410,967,000 | 1.54% |
JAMES INVESTMENT RESEARCH INC | 907,783 | $55,457,000 | 1.51% |
Global Thematic Partners, LLC | 1,450,231 | $88,596,000 | 1.40% |
Pergamon Offshore Advisors, L.P. | 24,297 | $1,484,000 | 1.39% |
Jupiter Investment Management Ltd | 631,217 | $38,561,000 | 1.37% |
CHASE INVESTMENT COUNSEL CORP | 52,601 | $3,213,000 | 1.14% |
DENALI ADVISORS LLC | 64,900 | $3,965,000 | 1.12% |
Copeland Capital Management, LLC | 249,530 | $15,244,000 | 1.10% |
Origin Asset Management LLP | 202,083 | $12,345,000 | 0.94% |